Iterum Therapeutics (ITRM) Institutional Ownership → [Urgent!] Generational Wealth Gameplan (From Crypto 101 Media) (Ad) Free ITRM Stock Alerts $1.50 +0.21 (+16.28%) (As of 05/31/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Iterum Therapeutics (NASDAQ:ITRM)CurrentInstitutional OwnershipPercentage9.21%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$214KNumber ofInstitutional Sellers(last 12 months)0 Get ITRM Insider Trade Alerts Want to know when executives and insiders are buying or selling Iterum Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ITRM Institutional Buying and Selling by Quarter Ad Crypto 101 Media[Urgent!] Generational Wealth GameplanA brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide Iterum Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/4/2023 Apollon Wealth Management LLC200,000$214K0.0%N/A1.542% 11/10/2022 New Leaf Venture Partners L.L.C.97,084$157K0.1%-93.3%0.794% 10/6/2022 Krilogy Financial LLC20,000$32K0.0%-90.0%0.163% 7/14/2022 Krilogy Financial LLC200,000$40K0.0%N/A0.109% 11/16/2021 Squarepoint Ops LLC52,503$29K0.0%+106.9%0.029% 11/15/2021 Franklin Resources Inc.384,200$215K0.0%N/A0.210% Get the Latest News and Ratings for ITRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Iterum Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021 Renaissance Technologies LLC644,567$360K0.0%-80.4%0.353% 10/25/2021 Krilogy Financial LLC81,000$45K0.0%+161.3%0.044% 9/17/2021 Virtu Financial LLC83,658$193K0.0%-37.2%0.046% 8/17/2021 Millennium Management LLC2,560,381$5.91M0.0%+3,304.5%1.429% 8/16/2021 Squarepoint Ops LLC25,382$59K0.0%-49.4%0.014% 8/16/2021 Cubist Systematic Strategies LLC89,431$207K0.0%N/A0.050% 8/13/2021 Renaissance Technologies LLC3,289,300$7.60M0.0%N/A1.836% 8/13/2021 Sigma Planning Corp17,153$40K0.0%N/A0.010% 8/13/2021QS Investors LLC384,200$888K0.0%N/A0.214% 8/12/2021 Insight Advisors LLC PA35,000$28K0.0%-88.5%0.020% 8/11/2021Susquehanna Fundamental Investments LLC66,230$153K0.0%N/A0.037% 8/10/2021 National Asset Management Inc.32,100$75K0.0%-61.0%0.018% 8/4/2021 Grimes & Company Inc.146,278$338K0.0%+17.4%0.082% 7/15/2021 Focused Wealth Management Inc100,000$231K0.0%+33.3%0.056% 5/21/2021 Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/19/2021 Virtu Financial LLC133,197$188K0.0%+209.0%0.074% 5/19/2021 Squarepoint Ops LLC50,196$71K0.0%N/A0.028% 5/18/2021 Millennium Management LLC75,206$106K0.0%N/A0.042% 5/18/2021 Verition Fund Management LLC112,500$159K0.0%N/A0.063% 5/18/2021 Citadel Advisors LLC137,026$193K0.0%-14.5%0.076% 5/18/2021 Jane Street Group LLC18,041$25K0.0%N/A0.010% 5/17/2021 Royal Bank of Canada19,000$27K0.0%N/A0.011% 5/17/2021 Edmond DE Rothschild Holding S.A.100,000$141K0.0%N/A0.056% 5/17/2021 HRT Financial LP399,479$563K0.0%+3,875.3%0.223% 5/13/2021 Barclays PLC50,000$71K0.0%N/A0.028% 5/12/2021 Geode Capital Management LLC96,173$135K0.0%+190.4%0.054% 5/12/2021 Grimes & Company Inc.124,637$176K0.0%+73.1%0.070% 5/12/2021 FineMark National Bank & Trust300,000$423K0.0%N/A0.167% 5/12/2021 UBS Group AG52,961$75K0.0%N/A0.030% 5/4/2021Commonwealth Equity Services LLC18,500$26K0.0%N/A0.010% 2/25/2021 Clear Street Markets LLC55,000$54K0.0%N/A0.045% 2/24/2021 Virtu Financial LLC43,111$43K0.0%N/A0.036% 2/10/2021 Renaissance Technologies LLC732,900$725K0.0%N/A1.493% 2/9/2021 Pivotal bioVenture Partners Investment Advisor LLC945,085$935K0.3%N/A1.926% Shocking $16T Elon Musk Crypto Leak (Ad)Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy.2/3/2021 Focused Wealth Management Inc75,000$74K0.0%N/A0.153% 2/2/2021 Grimes & Company Inc.72,000$71K0.0%N/A0.147% 5/11/2020 Ensign Peak Advisors Inc189,853$515K0.0%-17.7%1.317% 5/1/2020 UBS Group AG12,492$34K0.0%+542.3%0.089% (Data available from 1/1/2016 forward) ITRM Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ITRM shares? During the previous two years, the following institutional investors and hedge funds held shares of Iterum Therapeutics shares: Apollon Wealth Management LLC ($214K), and New Leaf Venture Partners L.L.C. ($157K), Krilogy Financial LLC ($32K).Learn more on ITRM's institutional investors. What percentage of Iterum Therapeutics stock is owned by institutional investors? 9.21% of Iterum Therapeutics stock is owned by institutional investors. Learn more on ITRM's institutional investor holdings. Which institutional investors have been buying Iterum Therapeutics stock? The following institutional investors have purchased Iterum Therapeutics stock in the last 24 months: Apollon Wealth Management LLC ($200K), and Krilogy Financial LLC ($200K). How much institutional buying is happening at Iterum Therapeutics? Institutional investors have bought a total of 400,000 shares in the last 24 months. This purchase volume represents approximately $814.60K in transactions. Which Iterum Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Iterum Therapeutics stock in the last 24 months: New Leaf Venture Partners L.L.C. ($1.36M), and Krilogy Financial LLC ($180K). How much institutional selling is happening at Iterum Therapeutics? Institutional investors have sold a total of 1,539,219 shares in the last 24 months. This volume of shares sold represents approximately $2.49M in transactions. Related Companies: Vaccitech Major Shareholders InflaRx Major Shareholders IO Biotech Major Shareholders Chimerix Major Shareholders Oncolytics Biotech Major Shareholders Assembly Biosciences Major Shareholders Marinus Pharmaceuticals Major Shareholders Benitec Biopharma Major Shareholders SELLAS Life Sciences Group Major Shareholders Anixa Biosciences Major Shareholders This page (NASDAQ:ITRM) was last updated on 6/1/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyUnlock Explosive Gains with This Defense StockBehind the MarketsNvidia is about to pass AppleWeiss RatingsClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe Worst is Yet to Come…Porter & CompanyDems have chosen Biden replacement?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Iterum Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
